Literature DB >> 25220543

Trifecta and optimal perioperative outcomes of robotic and laparoscopic partial nephrectomy in surgical treatment of small renal masses: a multi-institutional study.

Homayoun Zargar1, Mohamad E Allaf2, Sam Bhayani3, Michael Stifelman4, Craig Rogers5, Mark W Ball2, Jeffrey Larson3, Susan Marshall4, Ramesh Kumar5, Jihad H Kaouk1.   

Abstract

OBJECTIVE: To compare the perioperative outcomes of robotic partial nephrectomy (RPN) with laparoscopic PN (LPN) performed for small renal masses (SRMs), in a large multi-institutional series and to define a new composite outcome measure, termed 'optimal outcome' for the RPN group. PATIENTS AND METHODS: Retrospective review of 2392 consecutive cases of RPN and LPN performed in five high-volume centres from 2004 to mid-2013. We limited our study to SRMs and cases performed by surgeons with significant expertise with the technique. The Trifecta was defined as negative surgical margin, zero perioperative complications and a warm ischaemia time of ≤25 min. The 'optimal outcome' was defined as achievement of Trifecta with addition of 90% estimated glomerular filtration rate preservation and no chronic kidney disease stage upgrading. Univariable and multivariable analysis were used to identify factors predicting Trifecta and 'optimal outcome' achievement.
RESULTS: In all, 1185 RPN and 646 LPN met our inclusion criteria. Patients in the RPN group were older and had a higher median Charlson comorbidity index and higher R.E.N.A.L. nephrometry score. The RPN group had lower warm ischaemia time (18 vs 26 min), overall complication rate (16.2% vs 25.9%), and positive surgical margin rate (3.2% vs. 9.7%). There was a significantly higher Trifecta rate for RPN (70% vs 33%) and the rate of achievement of 'optimal outcome' for the RPN group was 38.5%.
CONCLUSIONS: In this large multi-institutional series RPN was superior to LPN for perioperative surgical outcomes measured by Trifecta. Patients in the RPN group had better outcomes for all three components of Trifecta compared with their LPN counterparts. Our more strict definition for 'optimal outcome' might be a better tool for assessing perioperative and functional outcomes after minimally invasive PN. This tool needs to be externally validated.
© 2014 The Authors. BJU International © 2014 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Trifecta; favourable outcome; laparoscopic partial nephrectomy; nephron-sparing surgery; perioperative outcomes; robotic partial nephrectomy

Mesh:

Year:  2015        PMID: 25220543     DOI: 10.1111/bju.12933

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  44 in total

Review 1.  Partial Nephrectomy in the Overweight Patient: an Overview.

Authors:  Ben Schurhamer; Nathan Littlejohn; Ehab Eltahawy; Rodney Davis; Mohamed Kamel
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  The value of blood oxygen level dependent (BOLD) imaging in evaluating post-operative renal function outcomes after laparoscopic partial nephrectomy.

Authors:  Guangyu Wu; Ruiyun Zhang; Haiming Mao; Yonghui Chen; Guiqin Liu; Jin Zhang
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

3.  Improved perioperative outcomes by early unclamping prior to renorrhaphy compared with conventional clamping during robot-assisted partial nephrectomy: a propensity score matching analysis.

Authors:  Daisuke Motoyama; Yuto Matsushita; Hiromitsu Watanabe; Keita Tamura; Toshiki Ito; Takayuki Sugiyama; Atsushi Otsuka; Hideaki Miyake
Journal:  J Robot Surg       Date:  2019-02-02

4.  3D printed renal cancer models derived from MRI data: application in pre-surgical planning.

Authors:  Nicole Wake; Temitope Rude; Stella K Kang; Michael D Stifelman; James F Borin; Daniel K Sodickson; William C Huang; Hersh Chandarana
Journal:  Abdom Radiol (NY)       Date:  2017-05

5.  Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study.

Authors:  Jean-Baptiste Beauval; Benoit Peyronnet; Thibaut Benoit; Bastien Cabarrou; Thomas Seisen; Mathieu Roumiguié; Benjamin Pradere; Zine-Eddine Khene; Quentin Manach; Gregory Verhoest; Mathieu Thoulouzan; Jerome Parra; Nicolas Doumerc; Romain Mathieu; Christophe Vaessen; Michel Soulié; Morgan Roupret; Karim Bensalah
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

Review 6.  Frontiers in robot-assisted retroperitoneal oncological surgery.

Authors:  Wesley W Ludwig; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

7.  An evaluation of the timing of surgical complications following nephrectomy: data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).

Authors:  Akshay Sood; Firas Abdollah; Jesse D Sammon; Victor Kapoor; Craig G Rogers; Wooju Jeong; Dane E Klett; Julian Hanske; Christian P Meyer; James O Peabody; Mani Menon; Quoc-Dien Trinh
Journal:  World J Urol       Date:  2015-04-25       Impact factor: 4.226

8.  Nephron sparing surgery for renal cell carcinoma up to 7 cm in the context of guideline development: a contribution of healthcare research.

Authors:  Steffen Lebentrau; Sven Rauter; Daniel Baumunk; Frank Christoph; Frank König; Matthias May; Martin Schostak
Journal:  World J Urol       Date:  2016-08-12       Impact factor: 4.226

9.  The First Pilot Comprehensive Evaluation of the Outcomes of Different Types of Robotic Surgeries in the Different Surgical Departments: The Penta, Tetra and Trifecta Achievements in Robotic Surgeries.

Authors:  Takehiro Sejima; Shuichi Morizane; Kazunori Fujiwara; Keigo Ashida; Hiroaki Saito; Yuji Taniguchi; Hiroshige Nakamura; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

10.  Non-modifiable factors predict discharge quality after robotic partial nephrectomy.

Authors:  Matthew J Maurice; Daniel Ramirez; Önder Kara; Ryan J Nelson; Peter A Caputo; Ercan Malkoç; Jihad H Kaouk
Journal:  Int Urol Nephrol       Date:  2016-09-26       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.